|4Feb 3, 7:37 PM ET

Crowley John J 4

4 · Fusion Pharmaceuticals Inc. · Filed Feb 3, 2022

Insider Transaction Report

Form 4
Period: 2022-02-01
Crowley John J
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-01+167,000167,000 total
    Exercise: $7.70Exp: 2032-02-01Common Stock (167,000 underlying)
  • Award

    Common Stock

    2021-08-31+3,91010,410 total
Footnotes (2)
  • [F1]These shares were purchased pursuant to the issuer's 2020 Employee Stock Purchase Plan.
  • [F2]This option vests in 48 equal monthly installments beginning on March 1, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION